An interventional study of Retrograde intrarenal surgery in Kidney Calculi and Kidney Stones, sponsored by Namik Kemal University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-07-08.
Sponsored by Namik Kemal University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 48 studies in Kidney Calculi with a site in Turkey — 21 open to participants now, 22 under way, none of them phase 3. Kidney Calculi · Turkey.
Among the 48 studies in Kidney Calculi with a site in Turkey, this one is the 10th largest by planned enrollment of the 35 interventional ones that give a count, is one of 4 that started in 2024, is one of 32 with no phase, reaches primary completion later than 5 of the 21 other live ones, and was the 22nd registered.
510 studies on the registry are indexed under Kidney Calculi; 147 are open to participants now.
Browse Kidney Calculi studies →21 of the 48 studies in Kidney Calculi with a site in Turkey are open now. Recruiting first, the newest first:
Aydin Adnan Menderes University · Sites in Turkey
Ages 18+
Hitit University · Sites in Turkey
Ages 18–75
Hitit University · Sites in Turkey
Ages 18–75
Hitit University · Sites in Turkey
Ages 18+
Hitit University · Sites in Turkey
Ages 18–75
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 88 Kidney Calculi studies recruiting now, 48 (55%) set no upper age limit and 23 (26%) stop at 75 or younger; 6 take children under 18; 11 take healthy volunteers.
This study: 18 Years to 85 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
48 studies; the count open now beside each. This study's row is marked.
First in 2014; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 150 is above the median of 86 across 392 interventional studies indexed under Kidney Calculi.
Median enrollment 90 across the 35 interventional studies, 184 across the 13 observational. Of the 18 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 48 has an industry lead sponsor. The 10 most frequent:
Namik Kemal University is the lead sponsor of 62 studies on the registry; 18 are open to participants now.
Namik Kemal University has 2 studies filed under Kidney Calculi — fewer than ten, so there is no comparison to draw.
9 of the studies in Kidney Calculi with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07763600Malatya Governor Research HospitalEffect of Anesthesia Type on Surgeon Workload During Endoscopic Kidney Stone Surgery | 2027-01 |
| NCT07512297University of GaziantepPain Control During ESWL Using Non-Opioid Analgesics | 2027-01-01 |
| NCT07721571Hitit UniversityNephrostomy Tract Infiltration for Pain Control After PCNL | 2027-01-11 |
| NCT07736924Emrah Kızılay2D:4D Digit Ratio and Urinary Stone Disease | 2027-01-31 |
| NCT07655050Hitit UniversityAntibiotic Irrigation and Suction Ureteral Access Sheath in RIRS | 2027-02-08 |
Add all 9 to your calendar (.ics) → With an account.
Among the 48 studies in Kidney Calculi with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to compare the efficacy and safety, the ratio of stone-free rates, and complications of two types of access sheaths used in retrograde intrarenal surgery to treat upper urothelial stones. The access sheath types are those with vacuum aspiration and the conventional ones.
The use of ureteral access sheath (UAS) during Retrograde Intrarenal Surgery (RIRS) has been proven effective and reliable in recent years, and publications indicate that it reduces stone-free rates (SFR). Their use is also recommended in the European Urology Guidelines because it improves image quality, reduces intrarenal pressure, and shortens the operation time. For this reason, it has been routinely used in many RIRS cases. In cases where non-vacuum-assisted UAS is used, fragments during stone fragmentation remain in the kidney, and since it is not possible to remove the stones simultaneously, the image may be distorted, and the operation duration may be prolonged. All these may pave the way for postoperative infectious complications. In addition to non-vacuum-assisted UAS, new UASs with flexible ends and vacuum-assisted aspiration have been introduced in the last few years (ClearPetra). Thanks to the aspiration connected to the system, stone fragments can be removed from the body with negative pressure during stone fragmentation. Continuous circulation prevents bleeding during fragmentation and blurring of the visual field due to stone fragments. In addition, since the stone fragments pass through the edges of the sheath without breaking and are removed, a perfect field of view can be provided. Unlike the classical UAS, the tip is flexible, allowing for the safe removal of lower pole stones. Many studies in the literature compare the success and complications of RIRS in cases where conventional UAS was used and not used. In addition, there are publications related to using the newly introduced aspiration access sheath in percutaneous nephrolithotomy. In retrospective publications on using this UAS in RIRS, it has been shown that stone-free rates, operation time, hemoglobin loss, and postoperative infective complications are more successful on the 1st and 30th postoperative days compared to cases where non-vacuum-assisted UAS was used. There is no randomized controlled prospective publication on this subject. This study aims to compare the complications and stone-free rates of RIRS cases where non-vacuum-assisted UAS and new vacuum-assisted UAS were used.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The patient population will be selected from cases determined by randomization and used with UAS without an aspiration (conventional) during RIRS.
Procedure: Retrograde intrarenal surgery
The patient population will be selected from cases determined by randomization and used with UAS with an aspiration and flexible tip, different from the conventional one during RIRS.
Procedure: Retrograde intrarenal surgery
Flexible optic devices and lasers fragment kidney stones during this operation. In this surgery, an ureteral access sheath is recommended to be used.
Stone free rates
Presence/absence of residual fragments in postoperative imaging, if any, diameter of longest axis in mm.
Time frame: Stone-free status will be checked by performing a non-contrast abdominal CT scan 1 month after the operation.
Complication rates
Peroperative and postoperative complication rates, whether UAS related or not
Time frame: Peroperative complication rates will be determined during the operation, and postoperative complications will be re-evaluated during hospitalization before discharge or in the first month after discharge.
Plan to share: No
Ran from Oct 2024 to primary completion in Oct 2025, 12 months.
Of 183 non-industry interventional studies with no phase under Kidney Calculi, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 54. This study's 12 months is below that.
Counting every sponsor, half of 199 studies reached it within 26 months; a quarter within 12 and three quarters within 51.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Namik Kemal University